FBC advises Orbimed in an investment in Keystone Heart, which develops and manufactures embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.
FBC advises the Orbimed Fund in an investment in Keystone Heart
By Raz Tepper | May 2014 | Transaction
Search by
- Arbitration & Mediation
- Aviation & Maritime
- Banking & Finance
- Blockchain and Cryptocurrency
- Capital Markets
- Class Actions & Derivative Suits
- Commercial
- Competition & Antitrust
- Cybersecurity, IT & Data Protection
- East Asia Desk
- Environmental
- Family & Inheritance Law
- FinTech
- French Desk
- Global Talent Mobility & Relocation
- Hi-Tech, Technology & Venture Capital
- Hotels & Tourism
- Insolvency & Restructuring
- Intellectual Property
- Investment Funds
- Labor & Employment
- Life Sciences & Healthcare
- Liquidation & Receivership
- Litigation
- Mergers & Acquisitions
- Philanthropy
- Planning & Zoning
- Private Asset Management
- Private Equity
- Project Finance & Energy
- Real Estate
- Regulatory
- Sports Law
- Tax
- Tax - Municipal Tax
- Tech Litigation
- Telecom & Media
- White Collar